Bell, Robert D.
University of Rochester Medical Center,
United States
2025 Rank: 95278
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 4044 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95278 | 109339 |
| Total Cites | 905 | 915 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 257 | 261 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 257 | 261 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 763 | 773 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.18 |
| Self-Citation Percentage |
1.09%
|
|
Bell, Robert D.
University of Rochester Medical Center,
United States
2024 Rank: 77754
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 3530 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77754 | 87663 |
| Total Cites | 852 | 871 |
| H-index | 15 | 15 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 243 | 248 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 243 | 248 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 702 | 713 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.22 |
| Self-Citation Percentage |
2.18%
|
|
Bell, Robert D.
University of Rochester Medical Center,
United States
2023 Rank: 59665
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 2963 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 59665 | 66226 |
| Total Cites | 909 | 940 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 334 | 347 |
| Number of Single+First+Last Authored Papers | 9 | 9 |
| Total Cites to Single+First+Last Authored Papers | 334 | 347 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 708 | 726 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.29 |
| Self-Citation Percentage |
3.30%
|
|
Bell, Robert D.
Pfizer Inc.,
United States
2022 Rank: 68953
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 3648 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68953 | 79856 |
| Total Cites | 855 | 884 |
| H-index | 15 | 15 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 339 | 351 |
| Number of Single+First+Last Authored Papers | 8 | 8 |
| Total Cites to Single+First+Last Authored Papers | 339 | 351 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 651 | 667 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.33 |
| Self-Citation Percentage |
3.28%
|
|
Bell, Robert D.
Pfizer Inc.,
United States
2021 Rank: 78719
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 4081 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78719 | 89657 |
| Total Cites | 1237 | 1279 |
| H-index | 17 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 502 | 522 |
| Number of Single+First+Last Authored Papers | 8 | 8 |
| Total Cites to Single+First+Last Authored Papers | 502 | 522 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 924 | 951 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.34 |
| Self-Citation Percentage |
3.28%
|
|
Bell, Robert D.
Pfizer Inc.,
United States
2020 Rank: 57485
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Immunology
Rank in SubField 1: 3145 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57485 | 61533 |
| Total Cites | 912 | 983 |
| H-index | 16 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 397 | 427 |
| Number of Single+First+Last Authored Papers | 8 | 8 |
| Total Cites to Single+First+Last Authored Papers | 397 | 427 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 685 | 716 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
7.22%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.